ezetimibe has been researched along with Ankylosing Spondylarthritis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, KH; Cho, ML; Choi, JW; Lee, AR; Lee, SY; Moon, J; Na, HS; Park, SH | 1 |
1 other study(ies) available for ezetimibe and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation.
Topics: Animals; Anti-Inflammatory Agents; Ezetimibe; Leukocytes, Mononuclear; Mice; Rosuvastatin Calcium; Spondylitis, Ankylosing; Th17 Cells | 2022 |